PATENT CLAIM ANALYSIS

Application Number: 15967187
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "210000"]

Abstract:
Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: wherein R 1  is as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, hyperkinetic disorders. Also disclosed are compositions containing these compounds in combination with a pharmaceutically acceptable carrier or diluent, as well as methods relating to the use in a subject in need thereof.

Claim (Index 2):
The compound of  claim 1 , wherein R 1  is hydrogen and the compound is [(2R,3S,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquinolin-2-yl]methanol, or a pharmaceutically acceptable salt or solvate thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.37097
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15627145', '15017480', '15116786', '11937445', '13237709']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8236080708188037
- 35 USC 102 Novelty (BERT): 0.6014008098140404
- Combined Prediction Score: 0.8013873447183274
- Mean Citation Score: 422.62164999999993
- Max Citation Score: 558.68744
- Similarity Product: 452.0105154410362

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test